Board Meeting2 Jun 2026, 04:02 pm
Goldline Pharmaceutical Board Meeting on June 9 to Approve Audited Results
AI Summary
Goldline Pharmaceutical Ltd has announced that its Board of Directors will convene on June 9, 2026. The primary agenda item is to consider and approve the standalone audited financial results for the half-year and full year ended March 31, 2026. The meeting will also address the statement of assets and liabilities. Further details on the outcome will be communicated separately.
Key Highlights
- Board meeting scheduled for June 9, 2026.
- To approve standalone audited financial results.
- Covers half-year and full year ended March 31, 2026.
- Statement of Assets and Liabilities to be approved.
Price Impact
More from GLPL